Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moshe Phillip

Showing results (311-320 of 334) with videos related to

Pageof 34
Sort By:
Pediatric Diabetes|September 11, 2012
Metabolic outcomes in young children with type 1 diabetes differ between treatment centers: the Hvidoere Study in Young Children 2009Carine E de Beaufort, Karin Lange, Peter G F Swift, et al.
Diabetes Care|June 2, 2007
Continuing stability of center differences in pediatric diabetes care: do advances in diabetes treatment improve outcome? The Hvidoere Study Group on Childhood DiabetesCarine E de Beaufort, Peter G F Swift, Chas T Skinner, et al.
Diabetes Technology & Therapeutics|March 24, 2022
Comparison of Insulin Dose Adjustments Made by Artificial Intelligence-Based Decision Support Systems and by Physicians in People with Type 1 Diabetes Using Multiple Daily Injections TherapyRevital Nimri, Amir Tirosh, Ido Muller, et al.
Diabetes, Obesity & Metabolism|June 10, 2018
Adjusting insulin doses in patients with type 1 diabetes who use insulin pump and continuous glucose monitoring: Variations among countries and physiciansRevital Nimri, Eyal Dassau, Tomer Segall, et al.
Pediatrics|April 1, 2009
Consensus statement on the use of gonadotropin-releasing hormone analogs in childrenJean-Claude Carel, Erica A Eugster, Alan Rogol, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Neuropsychological dysfunction and developmental defects associated with genetic changes in infants with neonatal diabetes mellitus: a prospective cohort study [corrected]Kanetee Busiah, Séverine Drunat, Laurence Vaivre-Douret, et al.
Diabetes Technology & Therapeutics|July 9, 2014
Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sitesHoward Zisser, Eric Renard, Boris Kovatchev, et al.
Diabetes Care|May 22, 2016
Multinational Home Use of Closed-Loop Control Is Safe and EffectiveStacey M Anderson, Dan Raghinaru, Jordan E Pinsker, et al.
The Lancet. Diabetes & Endocrinology|December 11, 2025
Continuous ketone monitoring for people with diabetes: international expert recommendations on the application of a new technologyKetan Dhatariya, Richard M Bergenstal, Mohammed Al-Sofiani, et al.
Journal of Diabetes Science and Technology|July 1, 2025
Early Stages of Automated Insulin DeliveryHoward Zisser, Roman Hovorka, Ananda Basu, et al.
Pageof 34

Showing results (311-320 of 334) with videos related to

Sort By:
Pageof 34
Pediatric Diabetes|September 11, 2012
Metabolic outcomes in young children with type 1 diabetes differ between treatment centers: the Hvidoere Study in Young Children 2009Carine E de Beaufort, Karin Lange, Peter G F Swift, et al.
Diabetes Care|June 2, 2007
Continuing stability of center differences in pediatric diabetes care: do advances in diabetes treatment improve outcome? The Hvidoere Study Group on Childhood DiabetesCarine E de Beaufort, Peter G F Swift, Chas T Skinner, et al.
Diabetes Technology & Therapeutics|March 24, 2022
Comparison of Insulin Dose Adjustments Made by Artificial Intelligence-Based Decision Support Systems and by Physicians in People with Type 1 Diabetes Using Multiple Daily Injections TherapyRevital Nimri, Amir Tirosh, Ido Muller, et al.
Diabetes, Obesity & Metabolism|June 10, 2018
Adjusting insulin doses in patients with type 1 diabetes who use insulin pump and continuous glucose monitoring: Variations among countries and physiciansRevital Nimri, Eyal Dassau, Tomer Segall, et al.
Pediatrics|April 1, 2009
Consensus statement on the use of gonadotropin-releasing hormone analogs in childrenJean-Claude Carel, Erica A Eugster, Alan Rogol, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Neuropsychological dysfunction and developmental defects associated with genetic changes in infants with neonatal diabetes mellitus: a prospective cohort study [corrected]Kanetee Busiah, Séverine Drunat, Laurence Vaivre-Douret, et al.
Diabetes Technology & Therapeutics|July 9, 2014
Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sitesHoward Zisser, Eric Renard, Boris Kovatchev, et al.
Diabetes Care|May 22, 2016
Multinational Home Use of Closed-Loop Control Is Safe and EffectiveStacey M Anderson, Dan Raghinaru, Jordan E Pinsker, et al.
The Lancet. Diabetes & Endocrinology|December 11, 2025
Continuous ketone monitoring for people with diabetes: international expert recommendations on the application of a new technologyKetan Dhatariya, Richard M Bergenstal, Mohammed Al-Sofiani, et al.
Journal of Diabetes Science and Technology|July 1, 2025
Early Stages of Automated Insulin DeliveryHoward Zisser, Roman Hovorka, Ananda Basu, et al.
Pageof 34